Daniel Diolaiti

3.0k total citations
21 papers, 952 citations indexed

About

Daniel Diolaiti is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Daniel Diolaiti has authored 21 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Daniel Diolaiti's work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Daniel Diolaiti is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Daniel Diolaiti collaborates with scholars based in United States, Italy and Australia. Daniel Diolaiti's co-authors include Robert N. Eisenman, Antônio Porro, Giuliano Della Valle, Giovanni Perini, Patrick A. Carroll, Lisa McFerrin, Michelle Ulrich, Nunzio Iraci, Steven Henikoff and Sheila S. Teves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Daniel Diolaiti

20 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Diolaiti United States	15	720	212	190	163	63	21	952
Ngan Ching Cheng Australia	13	681 0.9×	236 1.1×	109 0.6×	206 1.3×	186 3.0×	20	899
Kristoffer von Stedingk Sweden	17	568 0.8×	422 2.0×	175 0.9×	164 1.0×	55 0.9×	22	911
Roberto Tonelli Italy	19	677 0.9×	221 1.0×	230 1.2×	287 1.8×	112 1.8×	42	1.1k
Anthony Natoli Australia	14	484 0.7×	173 0.8×	308 1.6×	63 0.4×	34 0.5×	15	985
Ingrid Revet United States	13	757 1.1×	211 1.0×	169 0.9×	46 0.3×	109 1.7×	16	898
Tobias Sperka Germany	13	548 0.8×	89 0.4×	216 1.1×	212 1.3×	57 0.9×	14	1.0k
Susana Galli United States	14	357 0.5×	115 0.5×	331 1.7×	108 0.7×	94 1.5×	29	862
Magali Fernandez United States	8	612 0.8×	185 0.9×	66 0.3×	122 0.7×	112 1.8×	9	863
Weiyong Sun United States	15	717 1.0×	87 0.4×	107 0.6×	108 0.7×	80 1.3×	21	1.1k

Countries citing papers authored by Daniel Diolaiti

Since Specialization

Citations

This map shows the geographic impact of Daniel Diolaiti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Diolaiti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Diolaiti more than expected).

Fields of papers citing papers by Daniel Diolaiti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Diolaiti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Diolaiti. The network helps show where Daniel Diolaiti may publish in the future.

Co-authorship network of co-authors of Daniel Diolaiti

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Diolaiti. A scholar is included among the top collaborators of Daniel Diolaiti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Diolaiti. Daniel Diolaiti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Purohit, Vinee, Lidong Wang, Huibin Yang, et al.. (2021). ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Genes & Development. 35(3-4). 218–233. 30 indexed citations

Ortiz, Michael V., Daoqi You, Prabhjot S. Mundi, et al.. (2020). Preclinical evaluation of XPO1 inhibition in Wilms tumors.. Journal of Clinical Oncology. 38(15_suppl). 3580–3580.

Wang, Lidong, Huibin Yang, Andrea Zamperone, et al.. (2019). ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. Genes & Development. 33(11-12). 641–655. 21 indexed citations

Diolaiti, Daniel, Filemon S. Dela Cruz, Gunes Gundem, et al.. (2018). A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma. Molecular Case Studies. 4(6). a003194–a003194. 39 indexed citations

Marks, Lianna J., Daniel Diolaiti, Prabhjot S. Mundi, et al.. (2018). Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors.. Journal of Clinical Oncology. 36(15_suppl). 10552–10552. 3 indexed citations

Davé, Utpal P., Irina V. Lebedeva, Yao Shen, et al.. (2017). PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature. Molecular Cancer Therapeutics. 16(10). 2069–2082. 7 indexed citations

Hsiao, Susan J., Matthias A. Karajannis, Daniel Diolaiti, et al.. (2016). A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma. Molecular Case Studies. 3(2). a001396–a001396. 21 indexed citations

Cruz, Filemon S. Dela, Daniel Diolaiti, Andrew T. Turk, et al.. (2016). A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Genome Medicine. 8(1). 116–116. 14 indexed citations

Carroll, Patrick A., Daniel Diolaiti, Lisa McFerrin, et al.. (2015). Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis. Cancer Cell. 27(2). 271–285. 158 indexed citations

10.

Carroll, Patrick A. & Daniel Diolaiti. (2015). A novel role for the extended MYC network in cancer cell survival. Molecular & Cellular Oncology. 3(1). e1026528–e1026528. 3 indexed citations

11.

Diolaiti, Daniel, Lisa McFerrin, Patrick A. Carroll, & Robert N. Eisenman. (2014). Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1849(5). 484–500. 82 indexed citations

12.

Porro, Antônio, Nunzio Iraci, Simona Soverini, et al.. (2011). c-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia CD34+ Hematopoietic Progenitor Cells. Molecular Cancer Research. 9(8). 1054–1066. 38 indexed citations

13.

Young, Susan L., Daniel Diolaiti, Maralice Conacci‐Sorrell, et al.. (2011). Premetazoan Ancestry of the Myc–Max Network. Molecular Biology and Evolution. 28(10). 2961–2971. 53 indexed citations

14.

Porro, Antônio, Michelle Haber, Daniel Diolaiti, et al.. (2010). Direct and Coordinate Regulation of ATP-binding Cassette Transporter Genes by Myc Factors Generates Specific Transcription Signatures That Significantly Affect the Chemoresistance Phenotype of Cancer Cells. Journal of Biological Chemistry. 285(25). 19532–19543. 74 indexed citations

15.

Conerly, Melissa, Sheila S. Teves, Daniel Diolaiti, et al.. (2010). Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Genome Research. 20(10). 1383–1390. 103 indexed citations

16.

Iraci, Nunzio, Daniel Diolaiti, Antonella Papa, et al.. (2010). A SP1/MIZ1/MYCN Repression Complex Recruits HDAC1 at theTRKAandp75NTRPromoters and Affects Neuroblastoma Malignancy by Inhibiting the Cell Response to NGF. Cancer Research. 71(2). 404–412. 70 indexed citations

17.

Amente, Stefano, et al.. (2007). p14^ARF interacts with N‐Myc and inhibits its transcriptional activity. FEBS Letters. 581(5). 821–825. 13 indexed citations

18.

Diolaiti, Daniel, Roberto Bernardoni, Stefania Trazzi, et al.. (2007). Functional cooperation between TrkA and p75NTR accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities. Experimental Cell Research. 313(14). 2980–2992. 29 indexed citations

19.

Liu, Tao, Andrew E. Tee, Antônio Porro, et al.. (2007). Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proceedings of the National Academy of Sciences. 104(47). 18682–18687. 88 indexed citations

20.

Perini, Giovanni, Daniel Diolaiti, Antônio Porro, & Giuliano Della Valle. (2005). In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proceedings of the National Academy of Sciences. 102(34). 12117–12122. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact